Global Longlife Hospital and Research Ltd
Incorporated in 2015, Global Longlife Hospital & Research Ltd is a Multispecialty Hospital providing Medical & Allied Services
- Market Cap ₹ 33.6 Cr.
- Current Price ₹ 32.0
- High / Low ₹ 61.7 / 27.0
- Stock P/E
- Book Value ₹ 24.7
- Dividend Yield 0.00 %
- ROCE -2.04 %
- ROE -3.41 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -16.6% over past five years.
- Company has a low return on equity of 2.70% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 262 days.
- Working capital days have increased from 406 days to 749 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 33.44 | 33.32 | 32.70 | 32.44 | 23.38 | 13.51 | |
| 26.61 | 29.88 | 27.26 | 24.14 | 19.30 | 13.82 | |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.30 | 4.08 | -0.31 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | -2.29% |
| 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | 0.06 | |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.77 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 |
| Profit before tax | 2.69 | -1.07 | 1.75 | 5.71 | 2.70 | -2.27 |
| Tax % | 49.07% | -18.69% | -16.57% | 37.30% | 32.59% | -3.52% |
| 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | |
| EPS in Rs | 1.94 | -1.23 | 2.93 | 5.10 | 1.74 | -2.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -26% |
| TTM: | -42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -220% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 3% |
| Last Year: | -3% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 10.50 | 10.50 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 |
| 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | |
| 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.06 | |
| Total Liabilities | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.73 |
| 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 0.00 |
| Investments | 0.10 | 0.10 | 0.47 | 0.10 | 0.10 | 0.03 |
| 23.03 | 23.10 | 18.85 | 17.17 | 58.29 | 24.43 | |
| Total Assets | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.73 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| 5.40 | 3.90 | 6.88 | 9.42 | -40.42 | -5.07 | |
| -0.33 | -0.04 | 0.02 | 0.01 | -1.90 | -0.82 | |
| -4.77 | -3.05 | -7.22 | -9.66 | 45.70 | 2.67 | |
| Net Cash Flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Debtor Days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | |
| Inventory Days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | |
| Days Payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | |
| Cash Conversion Cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | |
| Working Capital Days | 82.85 | 78.21 | 57.82 | 36.34 | 433.07 | |
| ROCE % | 3.81% | 12.75% | 26.22% | 6.35% |
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
18 Jul - Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2024.
- Financial Results For The Half Year And Year Ended March 31, 2024 20 May
- Board Meeting Outcome for Audited Financial Results For The Half Year And Year Ended March 31, 2024 20 May
- Voting Results For EGM Held On 14Th May, 2024 In PDF Format. 16 May
- Shareholder Meeting / Postal Ballot-Outcome of EGM 14 May
Business Overview:[1]
Company is a Multi Speciality Tertiary Care Hospital of Gujarat with 110 beds equipped for Medical & Surgical specialties. Company is certified by National Accreditation Board for Hospitals and Healthcare Providers (NABH)